Telemedicine and smart insulin pens for diabetes
Part of Hormones & metabolism clinical trials.
This trial is testing whether a telemedicine program combined with smart insulin pens can help improve blood sugar control. It is for people with diabetes who use multiple daily insulin injections and have a smartphone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must take multiple daily insulin injections (at least one long-acting and one short-acting insulin) and have been doing so for at least 3 months
- You must not use an insulin pump
- You must not be pregnant
- You must have a smartphone that can run the required apps
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a smart insulin pen that connects with a continuous glucose monitor to help you manage your blood sugar. It may offer coaching tips to improve your insulin dosing.
This clinical trial tests whether using a smartphone app (called Caaring) can help people with diabetes on insulin better manage their blood sugar. If you take insulin and already monitor your blood sugar, this study may help you track your health remotely.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
This trial tests a smart phone-based system that helps doctors monitor diabetes and adjust insulin treatment. It could make blood sugar control easier for people with type 2 diabetes.
This study tests if smart insulin pens that connect to continuous glucose monitors can improve quality of life for people with diabetes who need help managing their treatment. If you use multiple daily injections, a glucose sensor, and rely on a healthcare provider, this trial may help find better ways to manage your condition.
This trial is testing a new automated insulin pump system that talks to your smartphone and lets the care team check on you from home. It helps people with type 1 diabetes better manage their blood sugar without extra trips to the clinic.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.